Skip to main content

Anti-inflammatory therapy for Alzheimer's disease: implications of the prednisone trial

Buy Article:

The full text article is temporarily unavailable.

We apologise for the inconvenience. Please try again later.

The inflammatory hypothesis of Alzheimer's disease (AD), which is supported both by basic laboratory evidence and epidemiological studies, suggests that treatment with anti-inflammatory drugs may reduce the risk or slow the progression of AD. In the first large-scale test of this hypothesis, the Alzheimer's Disease Cooperative Study (ADCS) conducted a randomized placebo-controlled trial of low-dose prednisone treatment in subjects with probable AD. There was no difference in cognitive decline between the prednisone and placebo treatment groups; subjects treated with prednisone showed behavioral decline compared to those in the placebo group. While this study indicates that a low-dose regimen of prednisone is not useful in the treatment of AD, it does not refute the inflammatory hypothesis; recent evidence supports testing of a number of alternative anti-inflammatory regimens, for prevention and/or treatment of AD. The ADCS has initiated a trial to determine whether treatment with a non-selective non-steroidal anti-inflammatory drug or a selective cyclooxygenase-2 inhibitor is effective in slowing the rate of cognitive decline in AD.

No References
No Citations
No Supplementary Data
No Data/Media
No Metrics

Keywords: Alzheimer's disease; cyclooxygenase-2; glucocorticoids; inflammation; non-steroidal anti-inflammatory drugs; therapeutic trials

Document Type: Original Article

Affiliations: Department of Neurology, Georgetown University Medical Center, 1 Bles Building, 3800 Reservoir Road NW, Washington, DC 20,007, USA

Publication date: 2000-12-01

  • Access Key
  • Free content
  • Partial Free content
  • New content
  • Open access content
  • Partial Open access content
  • Subscribed content
  • Partial Subscribed content
  • Free trial content
Cookie Policy
X
Cookie Policy
Ingenta Connect website makes use of cookies so as to keep track of data that you have filled in. I am Happy with this Find out more